Skip to content

Technology-Enabled Remote Hypertension Management To Advance Health Equity

Technology-Enabled Remote Hypertension Management To Advance Health Equity

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06331754
Enrollment
1500
Registered
2024-03-26
Start date
2024-03-18
Completion date
2026-03-17
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The primary objective of this study is to reliably estimate the difference in blood pressure control of a technology-enabled solution for blood pressure (BP) management over usual care. The study will also assess patient and provider satisfaction with the solution. Finally, the investigators will estimate the economic impact of the intervention in terms of resource utilization.

Detailed description

The study design is a non-blinded pragmatic cluster-randomized controlled trial with a single intervention. Participants with uncontrolled hypertension will be identified from a randomly selected group of primary care clinics. Participants from half of the clinics will be enrolled in the intervention arm while the others will receive usual care. Participants in the intervention arm will undergo a series of software-driven medication initiation and titration steps until they reach a blood pressure target of systolic blood pressure \< 130 mmHg and diastolic blood pressure \< 80 mmHg. Participants will be subsequently monitored for up to 12 more months.

Interventions

OTHERTechnology-enabled blood pressure management

The intervention will consist of a technology-enabled remote hypertension management program.

Sponsors

Atman Health, Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

non-blinded pragmatic cluster-randomized controlled trial with a single intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* 18 years - 100 years * uncontrolled hypertension: as defined as SBP \> 140 or DBP \> 90 on 2 successive clinic visits

Exclusion criteria

* hearing impaired * visually impaired * cognitively impaired * hospice care * on hemodialysis at enrollment * New York Heart Association Class IV heart failure

Design outcomes

Primary

MeasureTime frameDescription
Difference in SBP change6 months after enrollmentDifference in mean change in systolic blood pressure (SBP)

Secondary

MeasureTime frameDescription
HEDIS proportion6 months after enrollmentDifference in the proportion of patients meeting HEDIS definition of controlled hypertension (SBP \< 140 AND DBP \< 90) between intervention and usual care: overall and by patient group and by age, race, sex strata
Difference in DBP change6 months after enrollmentDifference in mean change in diastolic blood pressure (DBP)

Other

MeasureTime frameDescription
Mean time required per patient for provider6 monthsCumulative time in minutes for all interactions, including documentation.
Mean time required per patient for navigator6 monthsCumulative time in minutes for all interactions, including documentation.
Home measured change in SBP and DBP6 monthsHome measured change in blood pressure in intervention group - more accurately measured: overall and by patient group
Resource utilization18 monthsDifference in resource utilization between intervention and usual care for different patient groups using claims data.
Proportion of patients measuring blood pressure at directed frequency6 monthsProportion of patients measuring blood pressure at least twice a day during active management period.
Patient satisfaction6 monthsA patient satisfaction survey with questions similar to the Consumer Assessment of Healthcare Providers and Systems will be used.
Provider satisfaction6 monthsA survey instrument will be developed and administered to assess provider satisfaction with having a remote team manage their patients.

Contacts

Primary ContactRahul C Deo, MD PhD
rahul@atmanhealth.com339-204-5454

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026